During the "Golden Nine and Silver Ten" job-hopping season, the flow of talents in the pharmaceutical industry continues...

During the "Golden Nine, Silver and Ten" job-hopping season, the flow of talents in the pharmaceutical industry continues
.
According to incomplete statistics, in September alone, there were personnel changes in more than 10 pharmaceutical company executives, involving positions such as chairman, president, and general manager
.
The reasons for resignation mainly include personal reasons and job changes
.
General Manager of Weiguang Biological Resignation On September 30, Weiguang Biological issued an announcement stating that the company’s board of directors had recently received a resignation application from Mr.
Zhang Zhan, secretary of the company’s party committee, chairman and general manager
.
Due to his job change, he applied to resign from the position of general manager of the company and still served as secretary of the company’s party committee and chairman of the board after resignation
.
Chairman of Northeast Pharmaceutical resigns On September 28, Northeast Pharmaceutical issued an announcement stating that the company’s board of directors received a written resignation report from Mr.
Guo Qiyong on September 28, 2021
.
Due to job changes, Mr.
Guo Qiyong applied for resignation as the chairman of the company
.
After Guo Qiyong resigned, he still served as a director of the company's eighth board of directors, chairman of the strategy committee, and a member of the nomination committee
.
Yuexin Health President resigns On the 28th, Yuexin Health issued an announcement stating that the company's chairman and president Li Cixiong applied to the company's board of directors to resign as the company's president
.
After Li Cixiong resigned as president, he still served as chairman of the company
.
In addition, Song Yuancheng will assume the position of president of the company, while continuing to serve as director and chief financial officer of the company
.
Fosun Pharma’s vice president resigns On September 23, Fosun Pharma issued an announcement stating that the company’s board of directors received a written resignation letter from senior executive Ms.
Lihui Zou
.
Ms.
Lihui Zou applied to the company's board of directors to resign from the position of vice president due to personal reasons, and will no longer serve as the vice president from September 22, 2021
.
Chairman Si Litai resigns On September 16, Si Taili issued an announcement stating that the board of directors has recently received a written notice from Chairman Hu Jinsheng that due to his age, he has proposed to the board of directors to resign as chairman and will continue to serve as director and board of directors.
Member of the Strategy Committee
.
At the same time, the board of directors agreed to elect Hu Jian as the new chairman and chairman of the board's strategy committee, and to remove his vice chairman
.
BeiGene's senior vice president resigns.
On September 16, BeiGene internally announced major personnel changes, saying that Wu Qingyi, senior vice president of the company and chief commercial officer of Greater China, will leave the company to seek external development opportunities.
Wu Qingyi's last working day It is October 1, 2021
.
It is reported that Wu Qingyi joined BeiGene on June 19, 2019, and previously served as Vice President of Sanofi's China Specialty Medicines Division
.
Gan Li Pharmaceutical's Deputy General Manager resigns Gan Li Pharmaceutical issued an announcement on the evening of September 10 that the company's board of directors received a "resignation letter" from Deputy General Manager Lawrence Allan Hill.
Lawrence Allan Hill applied to resign from the company's deputy general manager due to personal reasons
.
In order to facilitate the handover of work, the company and Mr.
Lawrence Allan Hill agreed upon consensus that the resignation of Mr.
Lawrence Allan Hill will take effect on September 30, 2021
.
Foci Pharmaceuticals Deputy General Manager resigns On September 3, Foci Pharmaceuticals issued an announcement stating that due to job transfer, Lu Zhiying, deputy general manager and chief financial officer, resigned from the positions of deputy general manager and chief financial officer, and the resignation date is September 2, 2021.
After resignation, he no longer holds any positions in the company and its subsidiaries
.
It is understood that Lu Zhiying has served as the chief financial officer of the company on April 2, 2014, and has served as the deputy general manager of the company on August 26, 2014
.
Chairman of Hanhui Pharmaceuticals resigns On the evening of September 1, Hanhui Pharmaceuticals issued an announcement that starting from September 1, Liu Qi resigned as chairman of Hanhui Pharmaceuticals and was replaced by Chen Xiaohua
.
At the same time, the announcement showed that Hu Zhiqiang stepped down as CEO of Hanhui Pharmaceutical and was replaced by Li Yue
.
The company's LT team will report directly to CEO Li Yue
.